Improving Medication Adherence in Hypertensive Patients

NCT ID: NCT01826435

Last Updated: 2014-01-28

Basic Information

• Recruitment Status: WITHDRAWN
• Clinical Phase: NA
• Study Classification: INTERVENTIONAL
• Study Start Date: 2014-01-31
• Study Completion Date: 2015-05-31

Brief Summary

The study team is proposing a single arm intervention to test the effect of an electronic intervention on medication use among individuals with a prescription for hypertension/high blood pressure. The investigator proposes that technology like text messaging, email, web applications and mobile apps with proven, nurse intervention scripts, will lead to significant, cost-effective improvements in hypertension medication use.

Detailed Description

The intervention will incorporate a scalable electronic intervention using Email/Web Apps and Short Message Service (SMS)/Mobile Web Apps. The study team will examine the participants' responses to the electronic encounters in the technology-only intervention throughout the 3-month study timeframe.

Conditions

Hypertension

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: HEALTH_SERVICES_RESEARCH
• Blinding Strategy: NONE

Study Groups

Electronic Intervention

Over the three months, participants will receive a technology intervention. This will include text or email encounter notifications associated with appropriate mobile or online self-management information for medication adherence and behavior change.

Group Type: EXPERIMENTAL

Electronic Intervention

Intervention Type: BEHAVIORAL

Patients will be able to receive the intervention notifications over the electronic/multimedia mode they prefer; selecting either text messaging/mobile web and/or email/online web. Text message or email alerts with an included uniform resource locator (URL) link to the specified mobile or online web site will be utilized to notify patients of a pending encounter available on mobile. Topics that will be addressed in the intervention include medication and side effects, social support, hypertension knowledge, memory and smoking. All intervention encounters that are designed to collect responses from the patient will require the patient to supply credentials before responding to the encounter; thus, ensuring privacy of the patient session, as well as patient-specific tracking of responses.

Interventions

Electronic Intervention

Patients will be able to receive the intervention notifications over the electronic/multimedia mode they prefer; selecting either text messaging/mobile web and/or email/online web. Text message or email alerts with an included uniform resource locator (URL) link to the specified mobile or online web site will be utilized to notify patients of a pending encounter available on mobile. Topics that will be addressed in the intervention include medication and side effects, social support, hypertension knowledge, memory and smoking. All intervention encounters that are designed to collect responses from the patient will require the patient to supply credentials before responding to the encounter; thus, ensuring privacy of the patient session, as well as patient-specific tracking of responses.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Enrolled in the primary care clinic for the past 6 months
• New or existing prescription for hypertension
• Poorly controlled mean systolic blood pressure (SBP) in the last 12 months (>140/90 Hg)

Exclusion Criteria

• Hospitalized for a stroke, myocardial infarction, coronary artery revascularization in the past 3 months,
• Diagnosis of metastatic cancer;
• Active diagnosis of psychosis or dementia documented in medical record;
• Does not have access to the appropriate technology required
• Is not willing to use said device to receive notifications for the study;
• Does not live independently (assisted living or nursing home residents) or otherwise institutionalized or receiving home health care
• Severely impaired hearing, vision or speech (unless technological aides allow them full functionality)
• Planning to leave the area or change primary care clinics prior to the anticipated end of participation;
• Unable to read and understand spoken English
• Participation in another cardiovascular disease (CVD) study
• Another household member enrolled in study;
• Arm size > 50cm

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 75 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Duke University

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

Duke University Health System Clinic

Durham, North Carolina, United States

Countries

United States

Other Identifiers

Pro00043793

Identifier Type: -

Identifier Source: org_study_id